Gov. Cuomo to Sign Bill Making New York the 28th State to Provide PTSD Patients With Access to Medical Marijuana
The bipartisan proposal received overwhelming approval in the legislature
ALBANY, N.Y. - November 13, 2017 (Investorideas.com Newswire) Gov. Andrew Cuomo will sign a bipartisan bill to add post-traumatic stress disorder (PTSD) as a qualifying condition for New York's medical marijuana program, he announced on Saturday - Veterans Day. The Senate passed S 5629 in June (50-13), and the Assembly version, A 7006, received overwhelming approval in May (131-8). New York is the 28th state to allow medical marijuana to be used to treat PTSD.
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
"We thank Gov. Cuomo for his support of this compassionate bill. No one should have to leave the state to have access to a treatment that might help them have a better quality of life," said Landon Dais, political director for the Marijuana Policy Project of New York.
Assembly Health Committee chair Richard N. Gottfried, sponsor of the bill, said, "Governor Cuomo's action reflects growing recognition of the value of medical marijuana, and is another welcome step in the expanding and strengthening of New York's medical marijuana program."
"Gov. Cuomo should be applauded for helping thousands of New York veterans find relief with medical marijuana," said Bob Becker, legislative director for the New York State Council of Veterans Organizations. "PTSD is a serious problem facing our state, and now we have one more tool available to alleviate suffering."
Twenty-eight of the 29 states with medical marijuana programs will now allow patients with PTSD to qualify. In the only state that does not, Alaska, marijuana is legal and regulated for adults 21 and older. Bills to add PTSD to state medical marijuana programs were signed into law in Colorado, New Hampshire, and Vermont this year.
"Now, PTSD patients will have access to medical marijuana everywhere it is legally available," Dais said. "Over the past two years, New York has made important strides toward having an inclusive, workable medical marijuana program. We urge legislators, Gov. Cuomo, and the Department of Health to continue improving the program. To better serve patients, the state should expand qualifying conditions, allow patients to use the type of cannabis products that work best for them, and reduce burdensome rules that drive up prices."
The Marijuana Policy Project of New York promotes humane and just marijuana policies in New York state. For more information, visit www.MPPofNY.org.
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.